Circadian neuroendocrine physiology and electromagnetic field studies: Precautions and complexities

Radiation Protection Dosimetry

Volumn 106, Issue 4, 2003, Pages 369-373

  Warman, G R ^a   Tripp, H M ^b   Warman, V L ^b   Arendt, J ^b  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

CIRCADIAN RHYTHM; ELECTROMAGNETIC FIELD; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HORMONE SENSITIVITY; HORMONE SYNTHESIS; HUMAN; LIGHT EXPOSURE; NEUROENDOCRINE DISEASE; PINEAL BODY; REVIEW;

EID: 0346958379     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.rpd.a006374     Document Type: Review

References (36)

1. Wertheimer, N. and Leeper, E. Electrical wiring configurations and childhood cancer. Am. J. Epidemiol. 109, 273-284 (1979).
2. UK Childhood Cancer Study Investigators. Exposure to power-frequency magnetic fields and the risk of childhood cancer. Lancet 354(9194), 1925-1931 (1999).
3. Dockerty, J. D., Elwood, J. M., Skegg, D. C. and Herbison, G. P. Electromagnetic field exposures and childhood leukaemia in New Zealand. Lancet 354(9194), 1967-1968 (1999).
4. Schuz, J., Grigat, J. P., Brinkmann, K. and Michaelis, J. Residential magnetic fields as a risk factor for childhood acute leukaemia: results from a German population-based case-control study. Int. J. Cancer 91(5), 728-735 (2001).
5. Repacholi, M. H. and Ahlbom, A. Link between electromagnetic fields and childhood cancer unresolved. Lancet 354(9194), 1918-1919 (1999).
6. Erren, T. C. A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men. Bioelectromagnetics Suppl. 5, S105-S119 (2001).
7. Wever, R. The circadian system of man. (New York: Birkhaüser) (1979) ISBN 0 387 903380.
8. Berson, D. M., Dunn, F. A. and Takao, M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 295, 1070-1073 (2002).
9. Stevens, R. G. Electric power use and breast cancer: a hypothesis. Am. J. Epidemiol. 125, 556-561 (1987).
10. Kerenyi, N. A., Pandula, E. and Feuer, G. M. Oncostatic effects of the pineal gland. Drug Metabol. Drug Interact. 8(3-4), 313-319 (1990).
11. Blask, D. E., Sauer, L. A. and Dauchy, R. T. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr. Top. Med. Chem. 2(2), 113-132 (2002).
12. Lewy, A. J., Wehr, T. A., Goodwin, F. K., Newsome, D. A. and Markey, S. P. Light suppresses melatonin secretion in humans. Science 210(4475), 1267-1269 (1980).
13. Zeitzer, J. M., Dijk, D. J., Kronauer, R., Brown, E. and Czeisler, C. Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J. Physiol. 526, 695-702 (2000).
14. Thapan, K., Arendt, J. and Skene, D. J. An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J. Physiol. 535, 261-267 (2001).
15. Deacon, S. J. and Arendt, J. Phase-shifts in melatonin, 6-sulphatoxymelatonin and alertness rhythms after treatment with moderately bright light at night. Clin. Endocrinol. (Oxf). 40(3), 413-420 (1994).
16. Arendt, J. and Broadway, J. Phase response of human melatonin rhythms to bright light in Antartica. J. Physiol. 377, 68 (1986).
17. Klerman, E. B., Duffy, J. F., Dijk, D. J. and Czeisler, C. A. Circadian phase resetting in older people by ocular bright light exposure. J. Investig. Med. 49(1), 30-40 (2001).
18. Levallois, P., Dumont, M., Touitou, Y., Gingras, S., Masse, B., Gauvin, D., Kroger, E., Bourdages, M. and Douville P. Effects of electric and magnetic fields from high-power lines on female urinary excretion of 6-sulfatoxymelatonin. Am. J. Epidemiol. 154(7), 601-609 (2001).
19. Davis, S., Kaune, W. T., Mirick, D. K., Chen, C. and Stevens, R. G. Residential magnetic fields, light-at-night, and nocturnal urinary 6-sulfatoxymelatonin concentration in women. Am. J. Epidemiol. 154(7), 591-600 (2001).
20. Juutilainen, J., Stevens, R. G., Anderson, L. E., Hansen, N. H., Kilpelainen, M., Kumlin, T., Laitinen, J. T., Sobel, E. and Wilson, B. W. Nocturnal 6-hydroxymelatonin sulfate excretion in female workers exposed to magnetic fields. J. Pineal Res. 28(2), 97-104 (2000).
21. Crasson, M., Beckers, V., Pequeux, C., Claustrat, B. and Legros, J. J. Daytime 50 Hz magnetic field exposure and plasma melatonin and urinary 6-sulfatoxymelatonin concentration profiles in humans. J. Pineal Res. 31(3), 234-241 (2001).
22. Graham, C., Sastre, A., Cook, M. R. and Gerkovich, M. M. All-night exposure to EMF does not alter urinary melatonin, 6-OHMS or immune measures in older men and women. J. Pineal Res. 31(2), 109-113 (2001).
23. Graham, C., Cook, M. R., Gerkovich, M. M. and Sastre, A. Melatonin and 6-OHMS in high-intensity magnetic fields. J. Pineal Res. 31(1), 85-88 (2001).
24. Wood, A. W., Armstrong, S. M., Sait, M. L., Devine, L. and Martin, M. J. Changes in human plasma melatonin profiles in response to 50 Hz magnetic field exposure. J. Pineal Res. 25, 116-127 (1998).
25. Karasek, M., Woldanska-Okonska, M., Czernicki, J., Zylinska, K. and Swietoslawski, J. Chronic exposure to 2.9 mT, 40 Hz magnetic field reduces melatonin concentrations in humans. J. Pineal Res. 25(4), 240-244 (1998).
26. Griefahn, B., Kunemund, C., Blaszkewicz, M., Golka, K., Melmert, P. and Degen, G. Experiments on the effects of a continuous 16.7 Hz magnetic field on melatonin secretion, core body temperature, and heart rates in humans. Bioelectromagnetics 22(8), 581-588 (2001).
27. Griefahn, B., Kunemund, C., Blaszkewicz, M., Golka, K. and Degen, G. Experiments on effects of an intermittent 16.7-Hz magneticfield on salivary melatonin concentrations, rectal temperature, and heart rate in humans. Int. Arch. Occup. Environ. Health 75(3), 171-178 (2002).
28. Warman, V. L., Dijk, D. J., Warman, G. R., Arendt, J. and Skene, D. J. Phase advancing human circadian rhythms with short wavelength light. Neurosci. Lett. 342, 37-40 (2003).
29. Buxton, O. M., Lee, C. W., L'Hermite-Baleriaux, M., Turek, F. W. and Van Canter, E. Exercise elicits phase shifts and acute alterations of melatonin that vary with circadian phase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284(3), R714-R724 (2003).
30. Khalsa, S. B., Jewett, M. E., Cajochen, C. and Czeisler, C. A. A phase-response curve to single bright light pulses in human subjects. J. Physiol. 549(3), 945-952 (2003).
31. Cook, M. R., Graham, C., Kavet, R., Stevens, R. G., Davis, S. and Kheifets, L. Morning urinary assessment of nocturnal melatonin secretion in older women. J. Pineal Res. 28(1), 41-47 (2000).
32. Deacon, S. J. Manipulation of the human circadian system with bright light and melatonin (unpublished PhD thesis). University of Surrey, UK (1994).
33. Krauchi, K., Cajochen, C., Werth, E. and Wirz-Justice, A. Alteration of internal circadian phase relationships after morning versus evening carbohydrate-rich meals in humans. J. Biol. Rhythms 17(4), 364-376 (2002).
34. Hack, L. M., Lockley, S. W., Arendt, J. and Skene, D. J. The effects of low dose 0.5 mg melatonin on the free-running circadian rhythms ofblind subjects (submitted for publication).
35. Klerman, E. B., Zeitzer, J. M., Duffy, J. F., Khalsa, S. B. and Czeisler C. A. Absence of an increase in the duration of the circadian melatonin secretory episode in totally blind human subjects. J. Clin. Endocrinol. Metab. 86(7), 3166-3170 (2001).
36. Yerneni, L. K. and Jayaraman, S. Pharmacological action of high doses of melatonin on B16 murine melanoma cells depends on cell number at time of exposure. Melanoma Res. 13(2), 113-117 (2003).